A test involving six genes can accurately predict the survival of patients with diffuse large-B-cell lymphoma, the most common type of lymph node cancer in adults, US researchers report. Dr. Izidore S. Lossos, from Stanford University Medical Center in California, and co-workers used special tests to evaluate 36 genes in lymph node specimens obtained from 66 lymphoma patients.
